Severe Fetal Akinesia At 19 Weeks: A Case Report

Abstract

The term "fetal akinesia" is defined as a complete or partial absence of fetal movements. It can occur in isolation or be associated with other malformations, some of which can be lethal. The first observations of this syndrome were made by Péna and Shokeir in 1974 [1]. Since then, several cases have been reported, though the syndrome remains rare, with an estimated frequency between 1 in 3,000 and 1 in 15,000 births [2]. In some cases, the risk of recurrence can be as high as 25% [3]. In practice, the detection of fetal akinesia during an ultrasound examination is always a source of anxiety, accompanied by diagnostic, etiological, and therapeutic challenges.

References

Gonzales M, Egoroff C. Fetal akinesia: the phenotype. In: Couture A, Baud C, Sanguintaah M, Veyrac C. Congenital Malformations T 3. Sau-ramps médical, 2005, p. 293-8.

Bayat A, Petersen A, Møller M, Andersen G, Ebbesen F. Incidence of fetal akinesia/hypokinesia deformation sequence: a population-based study. Acta Paediatr 2009;98:3e4.

Collet M, Le Guern H, Boog G. Anomalies of fetal mobility. In: Gillet JY. Boog G, Dumez Y, Nisand I, Val-lette C. Ultrasound of Fetal Malformations. Ed. Vigot, 1993, p. 294-6.

Mohtisham FS, Sallam A, Shawli A. Lethal multiple pterygium syndrome. BMJ Case Rep. 2019 May 8;12(5). doi: 10.1136/bcr-2018-229045. PMID: 31068350; PMCID: PMC6506140.

Ravenscroft G, Sollis E, Charles AK, North KN, Baynam G, Laing NG. Fetal akinesia: review of the genetics of the neuromuscular causes. J Med Genet. 2011;48:793–801.

Michalk A, Stricker S, Becker J, Rupps R, Pantzar T, Miertus J, et al. Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders. Am J Hum Genet 2008;82:464e76.

McKeown CME, Harris R. An autosomal dominant multiple pterygium syndrome. J Med Genet 1988;25:96e103.

Carnevale A, López Hernández A, De los Cobos L. Familial pterygium syndrome with probably dominant transmission linked to the X chromosome. Rev Invest Clin 1973;25:237e44 [Spanish].

Carrera-García L, Natera-de Benito D, Dieterich K, de la Banda MGG, Felter A, Inarejos E, Codina A, Jou C, Roldan M, Palau F, Hoenicka J, Pijuan J, Ortez C, Expósito-Escudero J, Durand C, Nugues F, Jimenez-Mallebrera C, Colomer J, Carlier RY, Lochmüller H, Quijano-Roy S, Nascimento A. CHRNG-related nonlethal multiple pterygium syndrome: Muscle imaging pattern and clinical, histopathological, and molecular genetic findings. Am J Med Genet A. 2019 Jun;179(6):915-926. doi: 10.1002/ajmg.a.61122. Epub 2019 Mar 14. PMID: 30868735.

Morgan NV, Brueton LA, Cox P, et al. Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and Escobar variants of multiple pterygium syndrome. Am J Hum Genet 200

Kalampokas E, Kalampokas T, Sofoudis C, Deligeoroglou E, Botsis D. Diagnosing arthrogryposis multiplex congenita: a review. ISRN Obstet Gynecol. 2012;2012:264918. doi: 10.5402/2012/264918. Epub 2012 Sep 23. PMID: 23050160; PMCID: PMC3461621.

. Kowalczyk B, Feluś J (2016) Arthrogrypose : mise à jour des aspects cliniques, de l'étiologie et des stratégies de traitement . Arch Med Sd 12 : 10–24.

Desguerre I. Hypomobilité fœtale d’origine neuromusculaire. In: Cabrol D, Pons JC, Goffinet F. Traité d’obstétrique.Paris: Flammarion, 2003, p. 233-5.

Hall JG. PenaeShokeir phenotype (fetal akinesia deformation sequence) revisited. Birth Defects Res A Clin Mol Teratol 2009;85:677e94.

Pergande M, Motameny S, Özdemir Ö, Kreutzer M, Wang H, Daimagüler HS, Becker K, Karakaya M, Ehrhardt H, Elcioglu N, Ostojic S, Chao CM, Kawalia A, Duman Ö, Koy A, Hahn A, Reimann J, Schoner K, Schänzer A, Westhoff JH, Schwaibold EMC, Cossee M, Imbert-Bouteille M, von Pein H, Haliloglu G, Topaloglu H, Altmüller J, Nürnberg P, Thiele H, Heller R, Cirak S. The genomic and clinical landscape of fetal akinesia. Genet Med. 2020 Mar;22(3):511-523. doi: 10.1038/s41436-019-0680-1. Epub 2019 Nov 4. Erratum in: Genet Med. 2020 Aug;22(8):1426-1428. doi: 10.1038/s41436-020-0839-9. PMID: 31680123.